期刊文献+

社区慢性病管理对青光眼病情影响的初步研究 被引量:5

暂未订购
导出
摘要 青光眼是最主要的致盲眼病…,若能早期发现、终身定期随访和监测及有效控制眼压,大多数因青光眼而致盲是可避免的。我中心对部分慢性青光眼患者进行社区为基础的慢性病管理,开展科普教育,定期随访眼压,对眼压异常者实现转诊,由上级医院进行眼压控制。研究目的在于评估该慢性病管理模式对青光眼患者关于青光眼知识的认知、视功能维持的作用。
出处 《中国眼耳鼻喉科杂志》 2013年第1期42-43,共2页 Chinese Journal of Ophthalmology and Otorhinolaryngology
基金 上海市卫生局课题(2008161)
  • 相关文献

参考文献1

二级参考文献30

  • 1Alm A, Stjernschantz J, Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Ophthalmology 1995; 102: 1743-1752.
  • 2Aim A. Comparative phase Ⅲ clinical trial of latanoprost and timolol in patients with elevated intraocular pressure. Adv Prostaglandin Thromboxane Leukot Res 1995; 23: 527-532.
  • 3Camras CB, Aim A, Watson P, Stjernschantz J. Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups. Ophthalmology 1996; 103: 1916-1924.
  • 4Camras CB. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group. Ophthalmology 1996; 103: 138-147.
  • 5Fristrom B. A 6-month, randomized, double-masked comparison of latanoprost with timolol in patients with open angle glaucoma or ocular hypertension. Acta Ophthalmol Scand 1996; 74: 140-144.
  • 6Watson P, Stjernschantz J. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group. Ophthalmology 1996; 103: 126-137.
  • 7Brandt JD, Vandenburgh AM, Chen K, Whitcup SM. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: a 3-month clinical trial. Ophthalmology 2001; 108: 1023-1031.
  • 8DuBiner H, Cooke D, Dirks M, Stewart WC, VanDenburgh AM, Felix C. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure, a 30-day comparison with latanoprost. Survey Ophthalmol 2001; 45: S353-S360.
  • 9Gandolfi S, Simmons ST, Sturm R, Chen K, VanDenburgh AM, 13imatoprost Study Group 3. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv Ther 2001; 18:110-121.
  • 10Sherwood M, Brandt J. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Survey Ophthalmol 2001; 45: S361-S368.

共引文献1

同被引文献24

引证文献5

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部